AMPH - Amphastar Pharmaceuticals, Inc.
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Rancho Cucamonga,
United States
Type: Equity
AMPH price evolution
AMPH
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $144.53 | $271.04 | $151.28 | $176.85 |
| Short term investments | $114.71 | $35.3 | $16.74 | $18.48 |
| Net receivables | $114.94 | $118.99 | $104.72 | $100.64 |
| Inventory | $105.83 | $109.98 | $104.62 | $103.65 |
| Total current assets | $489.6 | $543 | $384.55 | $407.67 |
| Long term investments | $15.21 | $2 | $1.46 | $1.76 |
| Property, plant & equipment | $315.64 | $314.11 | $305.51 | $269.99 |
| Goodwill & intangible assets | $613.29 | $619.35 | $625.6 | $37.18 |
| Total noncurrent assets | $1023.31 | $1001.63 | $993.71 | $365.99 |
| Total investments | $129.92 | $37.3 | $18.2 | $20.23 |
| Total assets | $1512.91 | $1544.63 | $1378.27 | $773.66 |
| Current liabilities | ||||
| Accounts payable | $93.37 | $222.72 | $217.54 | $88.89 |
| Deferred revenue | ||||
| Short long term debt | $4.34 | $4.15 | $16.05 | $5.16 |
| Total current liabilities | $225.41 | $257.96 | $251.28 | $105.64 |
| Long term debt | $619.3 | $668.4 | $512.69 | $96.87 |
| Total noncurrent liabilities | $648.08 | $691.53 | $537.75 | $119.44 |
| Total debt | $623.64 | $672.56 | $528.74 | $102.03 |
| Total liabilities | $873.49 | $949.49 | $789.03 | $225.08 |
| Shareholders' equity | ||||
| Retained earnings | $409.27 | $373.1 | $323.88 | $297.75 |
| Other shareholder equity | -$8.48 | -$8.41 | -$8.32 | -$8.27 |
| Total shareholder equity | $639.42 | $595.14 | $589.24 | $548.58 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $144.53 | $156.33 | $126.59 | $94.51 |
| Short term investments | $114.71 | $21.86 | $12.52 | $15.18 |
| Net receivables | $114.94 | $88.97 | $78.8 | $66 |
| Inventory | $105.83 | $103.58 | $92.81 | $96.83 |
| Total current assets | $489.6 | $378.32 | $318.12 | $279.68 |
| Long term investments | $15.21 | $2.41 | $3.98 | |
| Property, plant & equipment | $315.64 | $264.57 | $271.49 | $280.71 |
| Goodwill & intangible assets | $613.29 | $37.3 | $38.87 | $40.62 |
| Total noncurrent assets | $1023.31 | $363.67 | $353.41 | $351.55 |
| Total investments | $129.92 | $24.28 | $16.5 | $15.18 |
| Total assets | $1512.91 | $741.99 | $671.53 | $631.24 |
| Current liabilities | ||||
| Accounts payable | $93.37 | $20.5 | $89.55 | $95.5 |
| Deferred revenue | ||||
| Short long term debt | $4.34 | $6.05 | $5.18 | $15.62 |
| Total current liabilities | $225.41 | $94.86 | $103.81 | $112.2 |
| Long term debt | $619.3 | $72.84 | $99.48 | $51.65 |
| Total noncurrent liabilities | $648.08 | $118.47 | $122.2 | $70.31 |
| Total debt | $623.64 | $102.58 | $104.66 | $67.27 |
| Total liabilities | $873.49 | $213.33 | $226.01 | $182.51 |
| Shareholders' equity | ||||
| Retained earnings | $409.27 | $271.72 | $180.34 | $117.77 |
| Other shareholder equity | -$8.48 | -$8.62 | -$6.76 | -$3.72 |
| Total shareholder equity | $639.42 | $528.66 | $445.52 | $402.31 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $178.1 | $180.56 | $145.71 | $140.02 |
| Cost of revenue | $81.97 | $72.15 | $72.97 | $66.18 |
| Gross Profit | $96.14 | $108.4 | $72.74 | $73.84 |
| Operating activities | ||||
| Research & development | $20.42 | $16.66 | $16.84 | $19.82 |
| Selling, general & administrative | $21.74 | $19.06 | $19 | $20.59 |
| Total operating expenses | $42.16 | $35.73 | $35.84 | $40.41 |
| Operating income | $53.98 | $72.68 | $36.9 | $33.43 |
| Income from continuing operations | ||||
| EBIT | $50.3 | $76.95 | $36.11 | $33.18 |
| Income tax expense | $4.67 | $14.03 | $6.38 | $6.75 |
| Interest expense | $9.46 | $13.7 | $3.6 | $0.4 |
| Net income | ||||
| Net income | $36.17 | $49.22 | $26.12 | $26.03 |
| Income (for common shares) | $36.17 | $49.22 | $26.12 | $26.03 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $644.39 | $498.99 | $437.77 | $349.85 |
| Cost of revenue | $293.27 | $250.13 | $238.03 | $206.51 |
| Gross Profit | $351.12 | $248.86 | $199.74 | $143.34 |
| Operating activities | ||||
| Research & development | $73.74 | $74.77 | $60.93 | $67.23 |
| Selling, general & administrative | $80.39 | $66.59 | $68.92 | $65.16 |
| Total operating expenses | $154.13 | $141.36 | $129.85 | $132.39 |
| Operating income | $196.99 | $107.5 | $69.89 | $10.95 |
| Income from continuing operations | ||||
| EBIT | $196.54 | $116.71 | $83.63 | $5.32 |
| Income tax expense | $31.83 | $23.48 | $20.63 | $3.54 |
| Interest expense | $27.16 | $1.85 | $0.89 | $0.37 |
| Net income | ||||
| Net income | $137.54 | $91.39 | $62.12 | $1.4 |
| Income (for common shares) | $137.54 | $91.39 | $62.12 | $1.4 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $36.17 | $49.22 | $26.12 | $26.03 |
| Operating activities | ||||
| Depreciation | $7.61 | $7.39 | $6.79 | $7.16 |
| Business acquisitions & disposals | -$5.58 | -$500.83 | ||
| Stock-based compensation | $4.62 | $4.64 | $4.87 | $6.11 |
| Total cash flows from operations | $23.86 | $64.33 | $54.92 | $40.38 |
| Investing activities | ||||
| Capital expenditures | -$9.44 | -$10.19 | -$9.05 | -$9.48 |
| Investments | -$91.93 | -$19.38 | $1.89 | $3.49 |
| Total cash flows from investing | -$103.05 | -$31.15 | -$508.58 | -$6.33 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$50 | -$0.13 | -$8.02 | |
| Net borrowings | -$50.64 | $134.49 | $418.39 | -$0.97 |
| Total cash flows from financing | -$47.08 | $86.61 | $428.11 | -$13.55 |
| Effect of exchange rate | -$0.24 | -$0.04 | -$0.02 | $0.02 |
| Change in cash and equivalents | -$126.51 | $119.76 | -$25.57 | $20.52 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $137.54 | $91.39 | $62.12 | $1.4 |
| Operating activities | ||||
| Depreciation | $28.95 | $27.32 | $25.46 | $20.49 |
| Business acquisitions & disposals | -$506.41 | |||
| Stock-based compensation | $20.24 | $17.86 | $18.69 | $20.5 |
| Total cash flows from operations | $183.5 | $89.18 | $97.99 | $57.27 |
| Investing activities | ||||
| Capital expenditures | -$38.17 | -$23.61 | -$27.46 | -$33.85 |
| Investments | -$105.93 | -$7.79 | $1.4 | -$1.15 |
| Total cash flows from investing | -$649.12 | -$32.78 | -$28.67 | -$36.41 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$58.14 | -$39.91 | -$28.87 | -$24.43 |
| Net borrowings | $501.26 | -$2.19 | $30.36 | -$0.88 |
| Total cash flows from financing | $454.09 | -$26.44 | -$37.02 | -$2.25 |
| Effect of exchange rate | -$0.28 | -$0.22 | -$0.22 | $0.35 |
| Change in cash and equivalents | -$11.8 | $29.75 | $32.08 | $18.96 |
News
Fundamentals
| Market cap | $1.86B |
|---|---|
| Enterprise value | $2.34B |
| Shares outstanding | 48.07M |
| Revenue | $644.39M |
|---|---|
| EBITDA | $225.48M |
| EBIT | $196.54M |
| Net Income | $137.54M |
| Revenue Q/Q | 31.91% |
| Revenue Y/Y | 29.14% |
| P/E ratio | 13.51 |
|---|---|
| EV/Sales | 3.63 |
| EV/EBITDA | 10.36 |
| EV/EBIT | 11.89 |
| P/S ratio | 2.88 |
| P/B ratio | 2.87 |
| Book/Share | 13.48 |
| Cash/Share | 3.01 |
| EPS | $2.86 |
|---|---|
| ROA | 10.56% |
| ROE | 23.19% |
| Debt/Equity | 1.37 |
|---|---|
| Net debt/EBITDA | 3.23 |
| Current ratio | 2.17 |
| Quick ratio | 1.70 |